Title : Galantamine treatment in Alzheimer's disease with cerebrovascular disease: responder analyses from a randomized, controlled trial (GAL-INT-6).

Pub. Date : 2008 Sep

PMID : 18308781






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 The proportion of patients responding by at least four-points on the ADAS-cog/11 was significantly greater for the galantamine group compared with placebo (33.6% versus 17.2%; P = 0.003). Galantamine alkylglycerone phosphate synthase Homo sapiens